NYSE:ELMD Electromed (ELMD) Stock Price, News & Analysis $27.07 -0.44 (-1.60%) Closing price 09/9/2026 04:00 PM EasternExtended Trading$27.11 +0.04 (+0.15%) As of 09/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About Electromed Stock (NYSE:ELMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Electromed alerts:Sign Up Key Stats Today's Range$26.89▼$27.9550-Day Range$27.07▼$46.3152-Week Range$23.01▼$47.40Volume78,100 shsAverage Volume77,109 shsMarket Capitalization$226.47 millionP/E Ratio36.09Dividend YieldN/APrice Target$43.75Consensus RatingModerate Buy Company Overview Electromed Inc. (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients. The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components. Electromed produces private-label and branded items that meet or exceed industry quality standards, supplying home healthcare providers, sleep clinics and respiratory therapists. Its integrated manufacturing processes—from material sourcing to final assembly—aim to ensure product consistency, quick turnaround times and cost efficiencies for its customers. Founded in 2003 and headquartered in Jacksonville, Florida, Electromed operates manufacturing and distribution facilities within the United States and maintains a growing international customer base. The company’s vertically integrated operations and emphasis on research and development support ongoing product innovation and regulatory compliance. Electromed’s management team draws on decades of experience in the medical device sector to guide strategic growth and expand market reach.AI Generated. May Contain Errors. Read More Electromed Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks68th Percentile Overall ScoreELMD MarketRank™: Electromed scored higher than 68% of companies evaluated by MarketBeat, and ranked 176th out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingModerate Buy Consensus RatingElectromed has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialElectromed has a consensus price target of $43.75, representing about 61.6% upside from its current price of $27.07.Amount of Analyst CoverageElectromed has only been the subject of 2 research reports in the past 90 days.Read more about Electromed's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Electromed is 36.09, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.80.Price to Earnings Ratio vs. SectorThe P/E ratio of Electromed is 36.09, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.78.Price to Book Value per Share RatioElectromed has a P/B Ratio of 5.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ELMD. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldElectromed does not currently pay a dividend.Dividend GrowthElectromed does not have a long track record of dividend growth. News and Social Media4.5 / 5News Sentiment1.13 News SentimentElectromed has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Electromed this week, compared to 1 article on an average week.Search Interest6 people have searched for ELMD on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Electromed to their MarketBeat watchlist in the last 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Electromed insiders have not sold or bought any company stock.Percentage Held by Insiders10.50% of the stock of Electromed is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions40.82% of the stock of Electromed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Electromed's insider trading history. Receive ELMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELMD Stock News HeadlinesElectromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main EventSeptember 9 at 4:05 PM | businesswire.comElectromed (ELMD) Keeps Growing While Wall Street Barely NoticesSeptember 3, 2026 | finance.yahoo.comIt’s not about GreenlandThe petrodollar arrangement that anchored the US dollar for 50 years quietly expired in June 2024. Since then, China has cut its Treasury holdings by 45% from their peak, and BRICS nations offloaded $47 billion of American debt in a single month. The Trump administration has responded with a $12 billion critical minerals stockpile called Project Vault, equity stakes in miners like MP Materials and Lithium Americas, and a push to secure resources from Greenland to Ukraine. Porter Stansberry lays out the full story in a new documentary, including five companies positioned at the chokepoints of what he calls Trump's New Dollar. | Porter & Company (Ad)Electromed slides 17% as CEO Jim Cunniff announces retirementAugust 27, 2026 | msn.comElectromed Inc (ELMD) (Q4 2026) Earnings Call Highlights: Record Revenue and 15th Consecutive ...August 26, 2026 | uk.finance.yahoo.comElectromed outlines $1.05M-$1.15M fiscal 2027 home care revenue per rep target while CEO plans April 2027 retirementAugust 26, 2026 | seekingalpha.comElectromed, Inc. (ELMD) Q4 2026 Earnings Call TranscriptAugust 25, 2026 | seekingalpha.comElectromed第四财季每股收益超预期，股价小幅下滑August 25, 2026 | cn.investing.comSee More Headlines ELMD Stock Analysis - Frequently Asked Questions How have ELMD shares performed this year? Electromed's stock was trading at $29.12 at the beginning of 2026. Since then, ELMD stock has decreased by 7.0% and is now trading at $27.07. How were Electromed's earnings last quarter? Electromed, Inc. (NYSE:ELMD) released its quarterly earnings results on Tuesday, November, 12th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.13. The company earned $14.67 million during the quarter. Electromed had a trailing twelve-month return on equity of 15.71% and a net margin of 11.34%. How will Electromed's stock buyback program work? Electromed's board initiated a stock buyback plan on Monday, March 10th 2025, which permits the company to repurchase $5,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 2.4% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its shares are undervalued. When did Electromed IPO? Electromed (ELMD) raised $10 million in an initial public offering (IPO) on the week of October 3rd 2011. The company issued 2,000,000 shares at a price of $4.00-$6.00 per share. Who are Electromed's major shareholders? Top institutional investors of Electromed include BlackRock Inc. (5.62%), Punch & Associates Investment Management Inc. (2.64%), Bank of New York Mellon Corp (0.56%) and Man Group plc (0.46%). Insiders that own company stock include James L Cunniff, Bradley M Nagel and Andrew Summers. View institutional ownership trends. How do I buy shares of Electromed? Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Electromed own? Based on aggregate information from My MarketBeat watchlists, some other companies that Electromed investors own include NVIDIA (NVDA), Enterprise Products Partners (EPD), Energy Transfer (ET), Meta Platforms (META), Pfizer (PFE), TransEnterix (TRXDW) and Avino Silver & Gold Mines (ASM). Company Calendar Last Earnings11/12/2024Today9/09/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 10 days, ELMD's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:ELMD CIK1488917 Websmartvest.com Phone(952) 758-9299Fax866-758-5077Employees160Year Founded1992Price Target and Rating Average Price Target for Electromed$43.75 High Price Target$50.00 Low Price Target$38.00 Potential Upside/Downside+61.6%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$1.31 Trailing P/E Ratio36.09 Forward P/E RatioN/A P/E GrowthN/ANet Income$5.15 million Net Margins11.34% Pretax Margin15.57% Return on Equity15.71% Return on Assets13.37% Debt Debt-to-Equity RatioN/A Current Ratio5.10 Quick Ratio4.74 Sales & Book Value Annual Sales$73.78 million Price / Sales3.07 Cash Flow$0.65 per share Price / Cash Flow41.36 Book Value$5.10 per share Price / Book5.31Miscellaneous Outstanding Shares8,366,000Free Float7,359,000Market Cap$226.47 million OptionableOptionable Beta0.46 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NYSE:ELMD) was last updated on 9/10/2026 by MarketBeat.com Staff. From Our PartnersWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | SponsoredThis sub-5 dollar stock operates next to SpaceX and Blue OriginA small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, ...Freedom Financial | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhat Is A Roth Conversion, And How Do I Set One Up?A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...SmartAsset | SponsoredJon Najarian's #1 Energy Trade for 2026Jon Najarian says he's never been more excited about an energy opportunity. SpaceX just went public at over $2...Banyan Hill Publishing | SponsoredGold majors have a big problemNewmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet prod...Golden Portfolio | SponsoredI found Rolls-Royce at $2 - now I see the same setup againIn 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
